Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin D Horne

Showing results (161-170 of 282) with videos related to

Pageof 29
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 9, 2022
D-dimer Thresholds to Exclude Pulmonary Embolism among COVID-19 Patients in the Emergency Department: Derivation with Independent ValidationJoseph R Bledsoe, Daniel Knox, Ithan D Peltan, et al.
Journal of Cardiac Failure|December 20, 2005
The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failureMatthew J Kolek, John F Carlquist, Surai Thaneemit-Chen, et al.
The American Journal of Cardiology|November 16, 2004
Frequency of elevation of C-reactive protein in atrial fibrillationJeffrey L Anderson, Chloe A Allen Maycock, Donald L Lappé, et al.
The American Journal of Cardiology|March 23, 2005
Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failureT Jared Bunch, Joseph B Muhlestein, Tami L Bair, et al.
Journal of Thrombosis and Thrombolysis|November 18, 2006
Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective studyJohn F Carlquist, Benjamin D Horne, Joseph B Muhlestein, et al.
European Journal of Preventive Cardiology|February 24, 2021
Association of periodic fasting lifestyles with survival and incident major adverse cardiovascular events in patients undergoing cardiac catheterizationCiera L Bartholomew, Joseph B Muhlestein, Jeffrey L Anderson, et al.
American Heart Journal|November 27, 2008
Genetic variation at the 9p21 locus predicts angiographic coronary artery disease prevalence but not extent and has clinical utilityJeffrey L Anderson, Benjamin D Horne, Matthew J Kolek, et al.
European Journal of Heart Failure|June 19, 2007
Similar transplantation outcomes in patients bridged with cardiac assist devices for acute cardiogenic shock versus chronic heart failureStavros G Drakos, Abdallah G Kfoury, James W Long, et al.
Cardiology|February 18, 2004
Which features of the metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease?Jeffrey L Anderson, Benjamin D Horne, Heath U Jones, et al.
American Journal of Nephrology|February 23, 2005
Serum uric acid independently predicts mortality in patients with significant, angiographically defined coronary diseaseTroy E Madsen, Joseph B Muhlestein, John F Carlquist, et al.
Pageof 29

Showing results (161-170 of 282) with videos related to

Sort By:
Pageof 29
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 9, 2022
D-dimer Thresholds to Exclude Pulmonary Embolism among COVID-19 Patients in the Emergency Department: Derivation with Independent ValidationJoseph R Bledsoe, Daniel Knox, Ithan D Peltan, et al.
Journal of Cardiac Failure|December 20, 2005
The role of a common adenosine monophosphate deaminase (AMPD)-1 polymorphism in outcomes of ischemic and nonischemic heart failureMatthew J Kolek, John F Carlquist, Surai Thaneemit-Chen, et al.
The American Journal of Cardiology|November 16, 2004
Frequency of elevation of C-reactive protein in atrial fibrillationJeffrey L Anderson, Chloe A Allen Maycock, Donald L Lappé, et al.
The American Journal of Cardiology|March 23, 2005
Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failureT Jared Bunch, Joseph B Muhlestein, Tami L Bair, et al.
Journal of Thrombosis and Thrombolysis|November 18, 2006
Genotypes of the cytochrome p450 isoform, CYP2C9, and the vitamin K epoxide reductase complex subunit 1 conjointly determine stable warfarin dose: a prospective studyJohn F Carlquist, Benjamin D Horne, Joseph B Muhlestein, et al.
European Journal of Preventive Cardiology|February 24, 2021
Association of periodic fasting lifestyles with survival and incident major adverse cardiovascular events in patients undergoing cardiac catheterizationCiera L Bartholomew, Joseph B Muhlestein, Jeffrey L Anderson, et al.
American Heart Journal|November 27, 2008
Genetic variation at the 9p21 locus predicts angiographic coronary artery disease prevalence but not extent and has clinical utilityJeffrey L Anderson, Benjamin D Horne, Matthew J Kolek, et al.
European Journal of Heart Failure|June 19, 2007
Similar transplantation outcomes in patients bridged with cardiac assist devices for acute cardiogenic shock versus chronic heart failureStavros G Drakos, Abdallah G Kfoury, James W Long, et al.
Cardiology|February 18, 2004
Which features of the metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease?Jeffrey L Anderson, Benjamin D Horne, Heath U Jones, et al.
American Journal of Nephrology|February 23, 2005
Serum uric acid independently predicts mortality in patients with significant, angiographically defined coronary diseaseTroy E Madsen, Joseph B Muhlestein, John F Carlquist, et al.
Pageof 29